Are you Dr. Coyle?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 64 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
375 Dixmyth Ave
Cincinnati, OH 45220Phone+1 513-853-1300Fax+1 513-451-1356- Is this information wrong?
Summary
- Dr. Thomas Coyle, MD is an oncologist in Cincinnati, Ohio. He is currently licensed to practice medicine in Ohio, Florida, and New York. He is affiliated with Select Specialty Hospital-Cincinnati, Good Samaritan Hospital, and Bethesda North Hospital.
Education & Training
SUNY Upstate Medical UniversityFellowship, Hematology and Medical Oncology, 1988 - 1989
Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 1985 - 1987- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1982 - 1985
SUNY Upstate Medical UniversityClass of 1982
Certifications & Licensure
NY State Medical License 1983 - Present
OH State Medical License 2015 - 2023
FL State Medical License 1996 - 2000- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow (FACP) American College of Physicians, 2007
Clinical Trials
- Rivaroxaban Effects in Subjects Who Have Undergone Gastric Bypass Surgery Start of enrollment: 2014 Dec 01
Publications & Presentations
PubMed
- 2 citationsComplete response to temozolomide in chronic lymphocytic leukemia.Archana Rao, Nisha S. Ramani, Robert Stoppacher, Thomas Coyle> ;Clinical Case Reports. 2017 May 31
- 2 citationsCrizotinib in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma in the setting of renal insufficiency: a case report.Shalin Kothari, Najam Ud-Din, Michele Lisi, Thomas Coyle> ;Journal of Medical Case Reports. 2016 Jun 14
- 14 citationsPPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation: A Randomized Phase II Study: BrUOG 244.Heinrich Elinzano, Michael Glantz, Maciej M. Mrugala, Santosh Kesari, David Piccioni, Lyndon Kim, Edward Pan, Shakeeb Yunus, Thomas Coyle, Kinsella Timothy, Devon Evan...> ;American Journal of Clinical Oncology. 2015 Dec 9
- Join now to see all
Professional Memberships
- Member
- Fellow
Hospital Affiliations
Bethesda North HospitalCincinnati, Ohio
Good Samaritan HospitalCincinnati, Ohio- Select Specialty Hospital-CincinnatiCincinnati, Ohio
